[Problematic drug interactions].
Neuvonen
P J
PJ
HYKS ja HY:n kliinisen farmakologian osasto Haartmaninkatu 4 00290 Helsinki. pertti.neuvonen@huch.fi
Kivistö
K
K
D000375:Aging / Q000378:metabolism; D002983:Clinical Competence / Q000592:standards; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions / Q000502:physiology*; D004790:Enzyme Induction / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000009:adverse effects; D006801:Humans; D008099:Liver / Q000201:enzymology; D008133:Long QT Syndrome / Q000139:chemically induced; D006899:Mixed Function Oxygenases / Q000378:metabolism; D010599:Pharmacokinetics
D004791:Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A
Lääkeaineiden ongelmalliset yhteisvaikutukset.